Teva Expects Launches To Hold North American Generics Sales At $4bn Per Year
• By Aidan Fry
A relatively stable trading environment and a healthy pipeline of launches should help Teva maintain its North American Generics sales at around $1bn per quarter, the firm believes • Source: Shutterstock
